IL154168A0 - Improved specificity in treatment of diseases - Google Patents

Improved specificity in treatment of diseases

Info

Publication number
IL154168A0
IL154168A0 IL15416800A IL15416800A IL154168A0 IL 154168 A0 IL154168 A0 IL 154168A0 IL 15416800 A IL15416800 A IL 15416800A IL 15416800 A IL15416800 A IL 15416800A IL 154168 A0 IL154168 A0 IL 154168A0
Authority
IL
Israel
Prior art keywords
diseases
treatment
improved specificity
specificity
improved
Prior art date
Application number
IL15416800A
Other languages
English (en)
Original Assignee
Ribapharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribapharm Inc filed Critical Ribapharm Inc
Publication of IL154168A0 publication Critical patent/IL154168A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15416800A 2000-08-22 2000-12-07 Improved specificity in treatment of diseases IL154168A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22694800P 2000-08-22 2000-08-22
US22687000P 2000-08-22 2000-08-22
US22687100P 2000-08-22 2000-08-22
PCT/US2000/033454 WO2002016382A1 (en) 2000-08-22 2000-12-07 Improved specificity in treatment of diseases

Publications (1)

Publication Number Publication Date
IL154168A0 true IL154168A0 (en) 2003-07-31

Family

ID=27397667

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15416800A IL154168A0 (en) 2000-08-22 2000-12-07 Improved specificity in treatment of diseases

Country Status (15)

Country Link
EP (1) EP1351966A1 (no)
JP (1) JP2004518618A (no)
KR (1) KR20030040415A (no)
CN (1) CN1460109A (no)
AU (1) AU2001220806A1 (no)
BR (1) BR0017318A (no)
CA (1) CA2416748A1 (no)
CZ (1) CZ2003460A3 (no)
HU (1) HUP0302882A3 (no)
IL (1) IL154168A0 (no)
MX (1) MXPA03001528A (no)
NO (1) NO20030762L (no)
PL (1) PL365879A1 (no)
TW (1) TW200414903A (no)
WO (1) WO2002016382A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1594459B1 (en) 2002-12-30 2010-02-17 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991078A (en) * 1971-06-01 1976-11-09 Icn Pharmaceuticals, Inc. N-substituted 1,2,4-triazoles
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
USRE29835E (en) * 1971-06-01 1978-11-14 Icn Pharmaceuticals 1,2,4-Triazole nucleosides
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US4093624A (en) * 1977-01-31 1978-06-06 Icn Pharmaceuticals, Inc. 1,2,4-Thiadiazolidine-3,5-dione
JPS6426593A (en) * 1987-07-21 1989-01-27 Asahi Glass Co Ltd Nucleoside derivative
US4925930A (en) * 1988-11-02 1990-05-15 Nucleic Acid Research Institute Synthesis and anti-leukemic activity of alkyl-1-(β-D-ribofuranosyl)[1,2,4]triazole-3-carboximidates

Also Published As

Publication number Publication date
CZ2003460A3 (cs) 2003-10-15
CN1460109A (zh) 2003-12-03
HUP0302882A2 (hu) 2003-12-29
KR20030040415A (ko) 2003-05-22
NO20030762L (no) 2003-04-22
BR0017318A (pt) 2004-06-15
JP2004518618A (ja) 2004-06-24
AU2001220806A1 (en) 2002-03-04
EP1351966A1 (en) 2003-10-15
PL365879A1 (en) 2005-01-10
CA2416748A1 (en) 2002-02-28
WO2002016382A1 (en) 2002-02-28
HUP0302882A3 (en) 2005-06-28
NO20030762D0 (no) 2003-02-18
MXPA03001528A (es) 2004-04-02
TW200414903A (en) 2004-08-16

Similar Documents

Publication Publication Date Title
GB0007193D0 (en) Treatment of movrmrnt disorders
EP1267798A4 (en) TREATMENT OF SKIN DAMAGE WITH POLYENYLPHOSPHATIDYLCHOLINE
IL155092A0 (en) Compounds useful in the treatment of inflammatory diseases
GB0015745D0 (en) Treatment of bone diseases
AU7863201A (en) Treatment of hyperproliferative diseases
AU5464601A (en) Treatment of scale
AU5040101A (en) Improved treatment of neovascularization
GB0001710D0 (en) Therapeutic treatment
AU5000001A (en) Treatment of vitiligo
GB2360453B (en) Treatment of skin conditions
IL154168A0 (en) Improved specificity in treatment of diseases
AU2096002A (en) Therapeutic treatment
GB0012186D0 (en) Treatment of cancer and neurological diseases
GB0020588D0 (en) Treatment of wounds
GB2381455B (en) Treatment of burns
EP1303281A4 (en) METHODS OF TREATMENT
AU1324002A (en) Treatment of demyelinating diseases
GB0013928D0 (en) Methods of treatment
GB0014904D0 (en) Methods of treatment
AU8679801A (en) Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
IL153788A0 (en) Treatment of eating disorders using carboxyalkylethers
GB0016197D0 (en) Treatment and prevention of disease
GB0030866D0 (en) Treatment and prevention of disease
GB0030865D0 (en) Treatment and prevention of disease
GB0003228D0 (en) Treatment of GI disorders